|
Thank you for visiting our blog. Cox Padmore Skolnik & Shakarchy LLP is a national and international interdisciplinary law firm. At Cox Padmore Skolnik & Shakarchy LLP, we represent both plaintiffs and defendants in matters that run the gamut of business, real estate and commercial matters. Our litigators' capabilities include sale of goods or services, business contract disputes, shareholder and partnership disputes, real estate disputes, insurance coverage disputes, bankruptcy, representing creditors and defendants in adversary proceedings, federal and state statutory claims, trust disputes, restrictive covenants and unfair competition, letters of credit, business fraud, shareholder rights, landlord-tenant, lender liability, and issues of professional negligence and other business related claims. We handle dual party as well as multi-party complex litigation at all levels of the court system. We have decided to create a web log that will be useful and informative for clients. This will be the place to look first for news and up-to-date information. Over the next couple of weeks, we’ll begin posting information about common legal concerns. If you have any questions you would like addressed in this blog, please don’t hesitate to contact us. Cox Padmore Skolnik & Shakarchy LLP
630 Third Avenue
19th floor
New York, NY 10017-6705
Phone: (212) 953-6633
Fax: (212) 949-6943
Two decisions from the United States District Court for the Southern District of New York say there is no conversion claim for loan proceeds
Continue Reading
Material appearing only in a recital preceding the contract is not part of the terms of the contract
Continue Reading
Recently a question arose as to whether it is permissible to compensate a witness for her testimony, particularly, where, as in our case, we believe that the prospective witness is not employed. Opinions of the New York State Bar Association say .....
Continue Reading
|
|
News
Pharmaceuticals
[09/08] Onyx Pharma enters Japanese drug development deal
[09/01] Botox-maker pays $600M to resolve investigation
[09/01] Pfizer buying FoldRx for undisclosed amount
[08/30] Genzyme rejects Sanofi-Aventis offer
[08/26] Novartis takes control of eye care firm Alcon
[08/25] Somaxon, Procter & Gamble co-promote insomnia drug
[08/24] Merck foundation adds to Botswana partnership
[08/23] FDA commissioner says agency needs more authority
[08/23] Biomerica gets European OK for dog allergy test
Back to Main
Web Resources
skolnik@cpsslaw.comFindLaw
Thomson West
U.S. Courts
Westlaw
United States Chamber of Commerce
FirstGov
Legislative Branch
Library of Congress
White House
Internal Revenue Service
National Weather Service
Yahoo!Maps
YellowPages.com
New York Times
Newspapers Online
USA Today
Wall Street Journal
AOL
Google
Yahoo!Legal Blog Directory
|
